The FDA has approved Orenitram (treprostinil) Extended-Release Tablets, from United Therapeutics, for the oral treatment of Pulmonary Arterial Hypertension (PAH)...
United Therapeutics Corporation announced that preliminary analysis indicates that the FREEDOM-EV clinical study of Orenitram (treprostinil) extended-release tablets in patients...
United Therapeutics announced that key data from the phase III FREEDOM-EV study of Orenitram (treprostinil) extended-release tablets shows that the...
A short induction of Remodulin (treprostinil) injection allowed study subjects to reach double the typical doses of Orenitram (treprostinil) extended-release tablets than patients who did not have a Remodulin induction